flurbiprofen has been researched along with lactic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chung, CP; Kim, DK; Lee, SJ; Nam, KH; Park, YJ | 1 |
| Aboul-Enein, HY; Radwan, MA | 1 |
| Egea, MA; Espina, M; García, ML; Valls, O; Vega, E | 1 |
| Ghosh, LK; Gupta, BK; Mukherjee, S; Ray, S; Sashmal, S; Thakur, RS | 1 |
| Chauvet, A; Egea, MA; Gamisans, F; García, ML; Lacoulonche, F; Vega, E | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Vega, E | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Garduño-Ramírez, ML; Sánchez, E; Vega, E | 1 |
| Barbato, G; Benarese, M; Blandini, F; Feligioni, M; Graziani, M; Imbimbo, BP; Lanzillotta, A; Mango, D; Mercuri, NB; Nicoletti, F; Nisticò, R; Panico, MB; Piccirilli, S; Pieraccini, S; Pizzi, M; Porrini, V; Schepisi, C; Sironi, M | 1 |
| Challa, VG; Dhommati, R; Jain, A; Khan, W; Muntimadugu, E; Shaheen, M | 1 |
| Langer, K; Lappe, S; Mulac, D | 1 |
| Angioni, C; Dressman, J; Gao, F; Janas, C; Kirsamer, L; Mäntele, W; Mast, MP; Wacker, MG | 1 |
12 other study(ies) available for flurbiprofen and lactic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biological effects of drug-loaded biodegradable membranes for guided bone regeneration.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anticoagulants; Becaplermin; Biodegradation, Environmental; Bone Regeneration; Cyclooxygenase Inhibitors; Flurbiprofen; Guided Tissue Regeneration; Lactic Acid; Membranes, Artificial; Platelet-Derived Growth Factor; Polyesters; Polymers; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Skull; Statistics, Nonparametric; Tetracycline | 1997 |
In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Carriers; Flurbiprofen; Lactic Acid; Male; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Wistar; Stereoisomerism | 2004 |
Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Buffers; Drug Compounding; Electrochemistry; Eye; Flurbiprofen; Irritants; Lactic Acid; Nanoparticles; Ophthalmic Solutions; Particle Size; Phosphates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Solutions; Surface-Active Agents | 2006 |
Design and optimization of NSAID loaded nanoparticles.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Stability; Feasibility Studies; Flurbiprofen; Kinetics; Lactic Acid; Models, Chemical; Models, Statistical; Nanoparticles; Nanotechnology; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reproducibility of Results; Solubility; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical | 2007 |
PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Cornea; Drug Carriers; Flurbiprofen; Lactic Acid; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Nanospheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2008 |
Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Ophthalmic; Analysis of Variance; Animals; beta-Cyclodextrins; Cornea; Cryoprotective Agents; Drug Stability; Epithelium, Corneal; Flurbiprofen; Freeze Drying; Gamma Rays; Lactic Acid; Male; Nanospheres; Particle Size; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits | 2012 |
Flurbiprofen PLGA-PEG nanospheres: role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Female; Flurbiprofen; Humans; Inflammation; Lactic Acid; Nanospheres; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Skin; Skin Absorption | 2013 |
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia.
Topics: Acetates; Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Cells, Cultured; Cyclopropanes; Electrophysiological Phenomena; Flurbiprofen; Hippocampus; In Vitro Techniques; Ischemia; Lactic Acid; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Rats, Wistar | 2014 |
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Brain; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Flurbiprofen; Lactic Acid; Lipids; Liver; Lung; Male; Myocardium; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Spleen | 2016 |
Polymeric nanoparticles - Influence of the glass transition temperature on drug release.
Topics: Drug Liberation; Flurbiprofen; Glass; Lactic Acid; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porphyrins; Solubility; Temperature; Transition Temperature | 2017 |
The dispersion releaser technology is an effective method for testing drug release from nanosized drug carriers.
Topics: Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Flurbiprofen; Lactic Acid; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids; Solubility; Technology, Pharmaceutical | 2017 |